Search form
Search
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
contact us
You are here
Home
»
companies
» PRV-300
PRV-300
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
Endpoints
JNJ
Provention Bio
IBD
inflammatory bowel disease
PRV-6527
Crohn's Disease
PRV-300
ulcerative colitis
Flag link:
